郑向前, 候秀坤, 高明. 2017年第二版NCCN甲状腺肿瘤指南解读[J]. 中国肿瘤临床, 2018, 45(1): 14-17. DOI: 10.3969/j.issn.1000-8179.2018.01.046
引用本文: 郑向前, 候秀坤, 高明. 2017年第二版NCCN甲状腺肿瘤指南解读[J]. 中国肿瘤临床, 2018, 45(1): 14-17. DOI: 10.3969/j.issn.1000-8179.2018.01.046
Zheng Xiangqian, Hou Xiukun, Gao Ming. Interpretation of the second edition of the NCCN guidelines for thyroid cancer in 2017[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 45(1): 14-17. DOI: 10.3969/j.issn.1000-8179.2018.01.046
Citation: Zheng Xiangqian, Hou Xiukun, Gao Ming. Interpretation of the second edition of the NCCN guidelines for thyroid cancer in 2017[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 45(1): 14-17. DOI: 10.3969/j.issn.1000-8179.2018.01.046

2017年第二版NCCN甲状腺肿瘤指南解读

Interpretation of the second edition of the NCCN guidelines for thyroid cancer in 2017

  • 摘要: 甲状腺肿瘤是内分泌系统最常见的恶性肿瘤。随着各学科基础研究与技术方法的不断发展,甲状腺肿瘤的临床诊断与治疗以及对甲状腺癌的认识也在不断地进步。在最新版美国国立综合癌症网(NCCN)指南中,甲状腺结节的术前评估、手术方式及范围、术后促甲状腺激素(TSH)抑制治疗等方面均有所改变,可为国内甲状腺结节的诊断与治疗提供借鉴。

     

    Abstract: Thyroid carcinoma is the most common cancer that affects the endocrine system. With the development of research methods and techniques of various disciplines, the clinical diagnosis, treatment, and understanding of thyroid carcinoma are constantly progressing. In the latest edition of the National Comprehensive Cancer Network (NCCN) guidelines, the preoperative evaluation of thyroid nodules, the mode and range of the operation, and the treatment involving postoperative thyroid stimulating hormone (TSH) suppression have changed, all of which can provide a reference for the diagnosis and treatment of thyroid nodules.

     

/

返回文章
返回